Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome - PubMed (original) (raw)
Comparative Study
Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome
N G Morgenthaler et al. Autoimmunity. 1997.
Abstract
Antibodies to the 40 kD antigen (identified as tyrosine phosphatase IA-2) and glutamate decarboxylase (GAD65) are strongly associated with insulin dependent diabetes mellitus (IDDM). However, antibodies to GAD (GADA) can appear in the absence of IDDM, particularly in stiff man syndrome (SMS) and in some individuals with autoimmune polyendocrine syndrome type II (APS II) and organ specific autoimmune diseases. The aim of this study was to compare the specificity of IA-2 antibodies (IA-2A) and GADA for IDDM by determining their frequency in different patient groups. IA-2A were present in 64/114 (56%) IDDM patients and 9/19 (47%) APS II patients with IDDM but in only 4/28 (14%) SMS patients. 1/24 (4%) APS II patients without IDDM and 1/113 (0.9%) patients with organ specific autoimmune disease had low level IA-2A. In contrast GADA were present in 77/114 (68%) IDDM patients and 17/19 (89%) APS II patients with IDDM, but also in 25/28 (89%) SMS patients, 5/24 (21%) APS II patients without IDDM and 22/113 (19%) patients with organ specific autoimmune diseases. Furthermore, within the group of new onset IDDM, IA-2A seemed to be associated with ICA and age: 63% of ICA positive IDDM patients had IA-2A (74% had GADA) increasing to 77% in the group below 20 years of age (69% for GADA). Our results demonstrate that IA-2A may be more specific for IDDM than GADA, as the latter are also present in patients with SMS, APS II without IDDM and organ specific autoimmune diseases. IA-2A were less frequent in older patients with IDDM than GADA or ICA. A combination of IA-2A and GADA detected 84% of total and 93% of ICA positive IDDM patients.
Similar articles
- Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
Pietropaolo M, Peakman M, Pietropaolo SL, Zanone MM, Foley TP Jr, Becker DJ, Trucco M. Pietropaolo M, et al. J Autoimmun. 1998 Feb;11(1):1-10. doi: 10.1006/jaut.1997.0170. J Autoimmun. 1998. PMID: 9480718 - IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M. Savola K, et al. Diabetologia. 1998 Apr;41(4):424-9. doi: 10.1007/s001250050925. Diabetologia. 1998. PMID: 9562346 - Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE. Westerlund A, et al. J Autoimmun. 2005 Mar;24(2):153-67. doi: 10.1016/j.jaut.2004.12.001. J Autoimmun. 2005. PMID: 15829408 - Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW, Jun HS. Yoon JW, et al. Ann N Y Acad Sci. 2001 Apr;928:200-11. doi: 10.1111/j.1749-6632.2001.tb05650.x. Ann N Y Acad Sci. 2001. PMID: 11795511 Review.
Cited by
- Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement : Diabetes mellitus and thyroid disorders: recommendations for clinical practice.
Guastamacchia E, Triggiani V, Aglialoro A, Aiello A, Ianni L, Maccario M, Zini M, Giorda C, Guglielmi R, Betterle C, Attanasio R, Borretta G, Garofalo P, Papini E, Castello R, Ceriello A. Guastamacchia E, et al. Endocrine. 2015 Jun;49(2):339-52. doi: 10.1007/s12020-014-0474-9. Epub 2014 Nov 18. Endocrine. 2015. PMID: 25403287 - Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.
Wägner AM, Santana A, Herńndez M, Wiebe JC, Nóvoa J, Mauricio D; T1DGC6. Wägner AM, et al. Diabetes Metab Res Rev. 2011 Jul;27(5):493-8. doi: 10.1002/dmrr.1189. Diabetes Metab Res Rev. 2011. PMID: 21744463 Free PMC article. - A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.
Riveros C, Mellor D, Gandhi KS, McKay FC, Cox MB, Berretta R, Vaezpour SY, Inostroza-Ponta M, Broadley SA, Heard RN, Vucic S, Stewart GJ, Williams DW, Scott RJ, Lechner-Scott J, Booth DR, Moscato P; ANZgene Multiple Sclerosis Genetics Consortium. Riveros C, et al. PLoS One. 2010 Dec 1;5(12):e14176. doi: 10.1371/journal.pone.0014176. PLoS One. 2010. PMID: 21152067 Free PMC article. - T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M, Saiz A, Casamitjana R, Castañer MF, Sanmartí A, Graus F, Jaraquemada D. Costa M, et al. Clin Exp Immunol. 2002 Sep;129(3):471-8. doi: 10.1046/j.1365-2249.2002.01931.x. Clin Exp Immunol. 2002. PMID: 12197888 Free PMC article. - Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2.
Seissler J, Schott M, Morgenthaler NG, Scherbaum WA. Seissler J, et al. Clin Exp Immunol. 2000 Nov;122(2):157-63. doi: 10.1046/j.1365-2249.2000.01352.x. Clin Exp Immunol. 2000. PMID: 11091269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous